Marco Antonio Ramírez Rodríguez: Endovascular Management of Pelvic Venous Hypertension in May–Thurner Syndrome
Marco Antonio Ramírez Rodríguez, Vascular Surgeon at Hospital de Manises and Hospital Vithas Turia, shared a post on LinkedIn։
՛՛46-year-old woman with long-standing chronic pelvic pain and recently developed hematuria.
No history of thrombotic events, but with an obstetric history of five miscarriages, elevated homocysteine levels, and left lower limb edema.
Imaging with CT angiography and diagnostic venography revealed:
- Significant compression of the left common iliac vein by the right common iliac artery (consistent with May–Thurner syndrome) and a left-to-right pelvic venous shunt.
- Anomalous drainage of the left renal vein into the iliac axis, a clinically relevant finding.
After thorough case evaluation and detailed planning, endovascular treatment was selected as the therapeutic option, aiming to relieve pelvic venous hypertension and improve the patient’s symptoms.
Procedure steps:
9 Fr introducer sheath. Catheterization to the inferior vena cava. IVUS® assessment (Boston Scientific) confirmed a 5 mm stenosis and dilation of the external iliac vein to 13 mm, with a target coverage length of 120 mm. Therefore, a 14 × 120 mm Abre stent (Medtronic) was implanted, followed by angioplasty using an Atlas Gold® balloon.
Final venography demonstrated correct stent deployment and preserved drainage of the left renal vein. The patient was discharged 24 hours later without local complications.
Special thanks to Óscar Merino Mairal for sharing his experience and guidance during the case—it was a privilege to have him at our center.
Thanks as well to Medtronic Cristina Dominguez, Jonathan Pulido Asensio Boston Scientific and to the interventional nursing team led by Jesús Aguilar Escriba, Vascular TEAM of Hospital de Manises. Head of Department Ángel Plaza and Noelia Garzón, Moisés Falcón Espínola․՛՛

Stay updated with Hemostasis Today.
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration
-
Aug 14, 2026, 16:26Antonio Paul: The Best Transfusion Is the One That Isn’t Needed
-
Aug 14, 2026, 16:24Thirunavukkarasu Angappan: What mRNA Manufacturing Teaches Us About Scaling Hemophilia Gene Therapy
-
Aug 14, 2026, 16:16Priyanka Raheja: Advancing Multidisciplinary Care for Women with Bleeding Disorders
-
Aug 14, 2026, 16:09Cristina Chang: Hemophilia B Gene Therapy BBM-H901 Approved in Macao
-
Aug 14, 2026, 16:03Muhammad Shaheer Bin Faheem: The Growing Mortality Divide in Thromboembolism and Hypertension
-
Aug 14, 2026, 15:53Peter Jaworski: Plasma Donation Myths and Why Plasma Matters
-
Aug 14, 2026, 15:50John Strouse: Why Older Adults with Sickle Cell Disease Should Be Included in Clinical Trials
-
Aug 14, 2026, 15:44Scott Cameron: Understanding Sex Differences in Platelet Biology